Cautiously optimistic about ivermectin’s new findings. In this video, I will tell you three reasons why I am cautiously optimistic about the negative findings of the latest ivermectin randomized control trial and why you should not be concerned.
*Vitamin D HOME TESTING KIT: https://amzn.to/31s5yJG ((Deficiency is less than 30 ng/ml and Optimal=50-60 ng/ml)
*COVID-19 HOME TESTING KIT: https://amzn.to/3lWq4f7
***If you found value in this video, smash the like button, it would mean a lot.
***If you are new to my channel hit the subscribe button for more videos like this, and if you are a subscriber, share with your family and friends so they can be aware and take action. I have a new line-up coming your way.***
**Sign up for your vaccine at this link: https://hypertensionresistanttotreatment.com/9udv
**Get ivermectin from a certified medical doctor near you or online at this link
**** For hypertension support from me, go to hypertensionresistanttotreatment.com
**** Listen to podcasts? Here is a podcast that I host with over 3000 downloads that will help you on your journey to good blood pressure control. Go to the Hypertension Resistant To Treatment Podcast at https://www.buzzsprout.com/765992.
#ivermectin #ivermectinandcovid19 #flccc
****
Subscribe to get weekly trending topics, tasty recipes (evidenced-based ingredients) with easy preparation instructions, and to get evidence-based lifestyle modifications for good blood pressure control.
****
Connect with me on social media with questions or to say hello! Thank you for watching and much more to come!
Facebook: https://www.facebook.com/tonya.breauxshropshire.3
Twitter: https://twitter.com/goodbpcontrol
Instagram: https://www.instagram.com/tonyal.breauxshropshire/?hl=en
Disclaimers:
This post may contain affiliate links. I may earn a small commission from qualifying purchases at no cost to you. Thanks in advance for your support!
Copyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education, and research.